Weichang K. Chen - Publications

Retraction Note: Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription.

Journal: Cancer cell international

Published: February 19, 2026

Association between volatile organic compound co-exposure and the prevalence of rheumatoid arthritis: a nationwide cross-sectional study.

Journal: Frontiers in public health

Published: August 28, 2025

Association of the waist-to-weight index with low back pain: a mediation analysis involving accelerated biological ageing.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: July 13, 2025

Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 11, 2025

Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.

Journal: The lancet. Gastroenterology & hepatology

Published: April 22, 2025

Plasma metabolomic analysis of patients with different severities acute pancreatitis.

Journal: World journal of emergency medicine

Published: January 06, 2025

Effect of 3-Day Linaclotide Administration to Reduce the Polyethylene Glycol Volume for Colonoscopy Bowel Preparation: A Multicenter, Noninferiority, Randomized Controlled Trial.

Journal: The American journal of gastroenterology

Published: November 06, 2024

Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 09, 2024

Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn's disease: correlation with disease severity and biologic efficacy.

Journal: American journal of translational research

Published: June 12, 2024

Identification of cell death-regulating genes as the potential biomarkers for inflammatory bowel disease.

Journal: Asian journal of surgery

Published: June 10, 2024

Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease.

Journal: Frontiers in pharmacology

Published: May 14, 2024

Indole‑3‑propionic acid alleviates intestinal epithelial cell injury via regulation of the TLR4/NF‑κB pathway to improve intestinal barrier function.

Journal: Molecular medicine reports

Published: March 29, 2024